Fujifilm Says Avigan Drug's Impact on Earnings Uncertain

Fujifilm Says Avigan Drug's Impact on Earnings Uncertain

   Tokyo, May 22 (Jiji Press)--Fujifilm Holdings Corp. <4901> refrained from releasing projections for fiscal 2020 in its earnings report Friday, citing uncertainty about the impact on its earnings of the Avigan drug, developed by a subsidiary and expected to be effective against COVID-19 disease.
   For fiscal 2019, which ended in March, the company booked a consolidated operating profit of 186,570 million yen, down 11.1 pct from the previous year, and a net profit of 124,987 million yen, down 9.5 pct, on sales of 2,315,141 million yen, down 4.8 pct.

To read a full story, please click here to find out how to subscribe.

(C)JIJI PRESS LTD., All rights reserved.